|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Loss for the year | |||||
| Adjustments to reconcile loss for the year to net cash used in operating activities: | |||||
| Depreciation | |||||
| Loss on fixed asset disposal | |||||
| Equity issuance costs | |||||
| Stock-based compensation | |||||
| Issuance of restricted shares as compensation to directors | |||||
| Amortization of original issue discount related to promissory note | |||||
| Shares issued to CEO for achieving of IP Agreement milestones | |||||
| Loss on equity issuance | |||||
| Change in fair value of derivative liability | |||||
| Loss on Series A warrant repurchase | |||||
| Discount amortization and interest expenses related to promissory notes | |||||
| Linkage difference on principal of loans from stockholders | |||||
| Changes in assets and liabilities: | |||||
| Decrease (increase) in other current assets | |||||
| Increase in accounts payable | |||||
| Increase (decrease) in other current liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investment activities: | |||||
| Purchase of property and equipment | |||||
| Net cash used in investment activities | |||||
| Cash flows from financing activities | |||||
| Net proceeds received from underwritten U.S. public offering | |||||
| Proceeds from convertible promissory notes | |||||
| Series A warrant repurchase | |||||
| Net proceeds from December 2025 private placement transaction | |||||
| Issuance of promissory notes and detachable warrants through private placement Transaction | |||||
| Issuance of convertible promissory notes - related parties | |||||
| Issuance of convertible promissory notes and bifurcated conversion feature through private placement transaction | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Change in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash at beginning of the year | |||||
| Cash, cash equivalents, and restricted cash at end of the year | |||||
| Supplemental disclosure of cash flow activities: | |||||
| (a) Net cash (received) paid during the year for: | |||||
| Interest | |||||
| (b) Non-cash investment and financing activities: | |||||
| Deemed dividend upon trigger of down round protection | |||||
| Fair value of equity classified warrants issued in connection with December 2025 private placement | |||||
| Recognition of right for use asset against a lease liability | |||||
| Settlement of liabilities with equity | |||||
| Derivative liability | |||||
| Conversion of debt into equity | |||||
Loading...